Reactions Weekly

, Volume 1683, Issue 1, pp 390–390 | Cite as

Ipilimumab/nivolumab

Type 2 diabetes mellitus and diabetic ketoacidosis: case report
Case report

Reference

  1. Changizzadeh PN, et al. Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma. Journal for ImmunoTherapy of Cancer 5: 97, No. 1, 19 Dec 2017. Available from: URL: http://doi.org/10.1186/s40425-017-0303-9 - USACrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations